Berlin Heals

Focus: Berlin Heals develops implantable electroceutical devices for neurology and cardiology, specifically subcutaneous microcurrent treatment systems. The company operates from Switzerland with minimal public disclosure of scale or stage.

Neurology

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Berlin Heals

AI assessmentNot Hiring

No open roles listed right now. Follow Berlin Heals to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

2/9 — Limited

Company HealthSolid

Pipeline

Early-stage

3 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Key Products

HALOTHANE

Not specified

Post-LOE

Legacy ANDA product in post-exclusivity market, likely non-core to company strategy.

Products & Portfolio (1)

Help build intelligence for Berlin Heals

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Early-stage opportunity in emerging electroceutical space with 3 active clinical programs targeting high-burden cardiology indications
Swiss headquarters provides access to precision medical device ecosystem and strong IP/regulatory environment
Neurology and cardiology focus areas represent high-value therapeutic markets with limited competition in device-based electroceutical approaches

Watch Out For

Minimal public financial data, funding disclosures, or headcount information suggests early/undisclosed stage with uncertain cash runway
Only 1 active job opening indicates extremely limited hiring velocity and potential organizational constraints

Generated by Claude from Berlin Heals's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Pipeline & Clinical Trials

Subcutaneous cardiac microcurrent treatment

Idiopathic Cardiomyopathy

N/A

Clinical Trials (1)

NCT06920030Performance of the Cardiac Microcurrent (C-MIC) System With a Less Invasively Placed Left Ventricular Lead

N/A

CMIC

Systolic Left Ventricular Dysfunction

N/A

Clinical Trials (1)

NCT04662034Performance and Safety of the Cardiac Microcurrent Therapy System

N/A

C-MIC system

Systolic Left Ventricular Dysfunction

N/A

Clinical Trials (1)

NCT05189860The C-MIC-II Follow-Up Study

N/A

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 1 approved product, 3 clinical trials

Top TAs: Cardiovascular

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Portfolio Health

Post-LOE1 (100%)

1 total products

Therapeutic Area Focus

Cardiovascular

1 pipeline

Marketed

Pipeline